Italy-USA, Enea Tech Foundation and Biomedical main partners at the event on cooperation in biotech

The appointment on the 4th at the Farnesina is the first high-level institutional and commercial meeting between Italian and US operators active in the biotechnology and life sciences sector

Enea Tech and Biomedical Foundation is the main partner of the conference “Italy-United States: International Cooperation on Biotechnology Emerging and the Life Sciences”, scheduled for Tuesday 14 November, at 9.30 am, in the International Conference Room of the Farnesina. This is the first high-level institutional and commercial meeting between Italian and US operators active in the biotechnology and life sciences sector for the start of long-term bilateral conversations with the aim of developing international partnerships with strategic allies of others Villages. The day of work will be opened by institutional greetings from the Vice President of the Council and Minister of Foreign Affairs and International Cooperation, Antonio Tajani.

The meeting will include speeches by the Minister of University and Research, Anna Maria Bernini, the Ministry of Business and Made Italy, Adolfo Urso, the Minister of Health, Orazio Schillaci, and the US ambassador of Italy and San Marino , Jack Markell.

Fondazione Enea Tech e Biomedical will participate in the panel “Financing the internalization of companies dealing with biotech and life sciences”, to delve deeper into the topic of Italy’s attractiveness abroad. More fluid and functional processes as part of the ‘One Health’ journey and a synergistic collaboration of all the players in the supply chain. It is possible to act in the value chain by generating culture, skills and innovation, and at the same time creating a connection between research, the academic world and businesses with the aim of developing useful and effective system proposals for the development of the sector in Italy” underlined the general director of the Enea Tech and Biomedical Foundation, Maria Cristina Porta.



Source-www.adnkronos.com